. 1998 Jan-Feb;56(1):100-3.

[Hypereosinophilia and hematologic analysers "formula approach"]

[Article in French]

Affiliations

Free article

[Article in French]

D Lusina et al. Ann Biol Clin (Paris). 1998 Jan-Feb.

Free article

. 1998 Jan-Feb;56(1):100-3.

¹ Service de biologie médicale, Centre hospitalier Robert-Ballanger, Aulnay-sous-Bois, France.

No abstract available

Similar articles

[Elevated eosinophilias (30-90%) and their place among parasitic and nonparasitic diseases (personal observations)].
Gherman I. Gherman I. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1989 Jul-Aug;41(4):381-4. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1989. PMID: 2573949 Romanian.
Significance of eosinophil counting in tumor associated tissue eosinophilia (TATE).
Alkhabuli JO, High AS. Alkhabuli JO, et al. Oral Oncol. 2006 Sep;42(8):849-50. doi: 10.1016/j.oraloncology.2005.11.023. Epub 2006 Jul 7. Oral Oncol. 2006. PMID: 16829160
Approach to Patients with Eosinophilia.
Kuang FL. Kuang FL. Med Clin North Am. 2020 Jan;104(1):1-14. doi: 10.1016/j.mcna.2019.08.005. Med Clin North Am. 2020. PMID: 31757229 Free PMC article. Review.
The severity of peripheral blood eosinophilia indicates an eosinophilia-associated disease corresponding to its level.
Okada R, Nakachi S, Inokuma S. Okada R, et al. Allergol Int. 2016 Jan;65(1):112-4. doi: 10.1016/j.alit.2015.07.006. Epub 2015 Aug 20. Allergol Int. 2016. PMID: 26666492 No abstract available.
Is eosinophilia helpful in diagnosing drug eruptions?
Berman B, Villa AM. Berman B, et al. Skinmed. 2002 Nov-Dec;1(2):147-8. doi: 10.1111/j.1540-9740.2002.01834.x. Skinmed. 2002. PMID: 14673343 Review. No abstract available.